AGBL4 - Agbl4 AGBL carboxypeptidase 4 Gene
Also Known as Ccp6l1; RGD1559973; RGD1564161
Species: Rattus norvegicus
Summary
Predicted to enable metallocarboxypeptidase activity and tubulin binding activity. Predicted to be involved in C-terminal protein deglutamylation; defense response to virus; and protein side chain deglutamylation. Predicted to act upstream of or within several processes, including axonal transport of mitochondrion; positive regulation of ubiquitin-dependent protein catabolic process; and regulation of blastocyst development. Predicted to be located in Golgi apparatus; cytosol; and microtubule organizing center. Orthologous to human AGBL4 (AGBL Carboxypeptidase 4). [provided by Alliance of Genome Resources, Apr 2022]
AGBL4 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001350232.1 | NP_001337161.1 | cytosolic carboxypeptidase 6 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cytosolic carboxypeptidase 6 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS00442 | AGBL4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service